Success at Speed Part 4: Commercial Manufacturing
October 12, 2020
Part 4 – how to prepare for the rapid set-up of commercial manufacturing
0 min read
Success at Speed Part 5: Reducing Costs
October 16, 2020
Part 5 – reducing costs. Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price. The key is to strike a balance between price and development costs.
0 min read
Success at Speed Part 6: Logistics and Global Availability
October 20, 2020
Part 6 – logistics and global availability. A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.
0 min read
Success at Speed: Digging into Accelerated Vaccine Development (Part 1)
August 6, 2020
Part 1 – the need for speed and safety. As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely – for COVID-19 and other therapeutic areas.
0 min read
Success at Speed Part 2: Regulatory Considerations
August 6, 2020
Part 2 – regulatory considerations. It is well accepted that vaccine development needs to move faster, but what are the regulatory considerations and how can companies balance compliance and speed?
0 min read
Success at Speed Part 7: Progress So Far
December 1, 2020
Part 7 – Progress so far. There is a promising pipeline of vaccine candidates, but what happens if the frontrunners fail?
1 min read
Success at Speed Part 8: Lessons to be Learned
December 4, 2020
Part 8 – Lessons to be learned. What have we learned from the pandemic and how can we address the coming challenges?
1 min read
Success at Speed Part 3: Vaccine Modalities
September 8, 2020
Part 3 – vaccine modalities. Virus-based vaccines were the first foray into immunization, but the field had to move on, embracing recombinant proteins, and now viral vectors and mRNA vaccines.
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
